RT @4baseCare: The recent pharmacologic targeting of PIK3CA mutations has shown significant benefits after the occurrence of endocrine ther…
2 followers
13 followers
RT @4baseCare: The recent pharmacologic targeting of PIK3CA mutations has shown significant benefits after the occurrence of endocrine ther…
362 followers
The recent pharmacologic targeting of PIK3CA mutations has shown significant benefits after the occurrence of endocrine therapy resistance. Thereby indicating a great promise as a molecular target for HR+/HER2− mBC. LINK: https://t.co/EmPkbVrJjV #MedTwit
391 followers
RT @FrontOncology: 📣 Review on PIK3CA mutations as targets for HR+ HER2- #metastatic #BreastCancer by @NicolaFuscoMD, @UmbertoMalapel et al…